Harrow Stock

Harrow Financial Leverage

The Financial Leverage (Equity Multiplier) of Harrow (HROW) as of Aug 7, 2026 is 7.62. In the previous year, Financial Leverage (Equity Multiplier) was 5.58 — a change of 36.40% (higher).

Financial Leverage

7.62

YoY

36.40%

Last updated:

Financial Leverage (Equity Multiplier) of Harrow is 2026 7.62 . Financial Leverage (Equity Multiplier) of Harrow was 2025 5.58 . It decreases by 36.40% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Financial Leverage (Equity Multiplier) of Harrow is 7.62 in 2026.

Financial Leverage (Equity Multiplier) of Harrow changed from 5.58 to 7.62, representing a 36.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Harrow since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Harrow with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Harrow

All Key Metrics — Harrow